Global Alzheimer’s Disease Treatment Market Set For 6.8% Growth, Reaching $8.35 Billion By 2028

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only!

LONDON, GREATER LONDON, UNITED KINGDOM, December 18, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

The alzheimer’s disease treatment market has seen robust growth in recent years. The rise from $5.93 billion in 2023 to an estimated $6.41 billion in 2024, with a compound annual growth rate CAGR of 8.2%, is due to advancements in research, drug approvals and market entry, government initiatives and funding, as well as public awareness and education.

What Is The Projected Growth Rate and Market Size of the Global Alzheimer’s Disease Treatment Market?

The alzheimer’s disease treatment market is predicted to exhibit significant growth in the forthcoming years, likely to reach an estimated market size of $8.35 billion by 2028, experiencing a compound annual growth rate CAGR of 6.8%. The expected growth during the forecast period can be attributed to precision medicine approaches, rising healthcare expenditure, the global burden of disease, research in genetics and biomarkers, and emerging markets.

Find out more about the industry by viewing a sample report here: https://www.thebusinessresearchcompany.com/sample.aspx?id=3409&type=smp

What Are The Key Drivers For The Alzheimer's Disease Treatment Market?

One central driving force behind the thriving alzheimer’s disease treatment market is the increasing instances of Alzheimer's, the most common form of dementia. Projections indicate a steep rise in the number of Alzheimer's patients; for instance, in the US, all states are expected to see at least a 14% increase in Alzheimer's patients by 2025, primarily due to an aging population. Globally, new cases of Alzheimer's are expected to grow by 35% to 615,000 by 2030, and by a whopping 110% to 959,000 by 2050. Therefore, the escalating prevalence of Alzheimer's disease will likely drive the demand and subsequent growth of the global alzheimer’s disease treatment market.

Explore the full report for a comprehensive viewpoint on this topic: https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

Who Are The Major Key Players in the Alzheimer’s Disease Treatment Market?

A myriad of significant companies operating in the Alzheimer’s disease market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., UCB S.A., Eisai Co. Ltd., Forest Laboratories LLC, Ono Pharmaceutical Co. Ltd., H. Lundbeck A/S, Allergan plc, and many more. These industry giants have greatly contributed to recent advancements and developments in the treatment of Alzheimer's disease.

What Key Trends Are Impacting the Alzheimer's Disease Treatment Market?

The Alzheimer's disease treatment market is seeing a surge in R&D investments and collaborations due to emerging treatment technologies, with organizations such as The Alzheimer's Association providing funding to proactive researchers seeking innovative therapeutic approaches. For instance, Comentis and Astellas ventured into the BACE inhibitor field with their peptidomimetic series, thus affirming the importance of collaborative efforts in pushing boundaries for treatment.

The alzheimer’s disease treatment market can be segmented according to the following categories:
1 By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
2 By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists
3 By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

What Is the Regional Variation in Alzheimer's Disease Treatment Market Growth?

In 2023, North America held the largest share of the Alzheimer's disease treatment market. However, during the forecast period, the Middle East region is expected to be the fastest-growing, and the regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and Africa.

Explore other market research reports with similar insights by The Business Research Company:

Browse Through More Similar Reports By The Business Research Company:
Neurodegenerative Disorder Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report
Inflammatory Bowel Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report
Genetic Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

For Further Queries:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn